Clinical trial
IACS-010759 in Advanced Cancers
NCT03291938
Study timeline
Study start (actual)2017-11-13Date precision: day
Registry last updated2020-11-24
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Advanced Malignant Solid Neoplasmunresolved
Anatomic Stage III Breast Cancer AJCC v8unresolved
Anatomic Stage IV Breast Cancer AJCC v8unresolved
Estrogen Receptor Negativeunresolved
HER2/Neu Negativeunresolved
Metastatic Malignant Solid Neoplasmunresolved
Pancreatic Ductal Adenocarcinomaunresolved
Progesterone Receptor Negativeunresolved
Recurrent Lymphomaunresolved
Refractory Lymphomaunresolved
Stage II Pancreatic Cancer AJCC v8unresolved
Stage IIA Pancreatic Cancer AJCC v8unresolved
Stage IIB Pancreatic Cancer AJCC v8unresolved
Stage III Pancreatic Cancer AJCC v8unresolved
Stage IV Pancreatic Cancer AJCC v8unresolved
Triple-Negative Breast Carcinomaunresolved
Unresectable Solid Neoplasmunresolved
Interventions
Sponsors & collaborators
M.D. Anderson Cancer Centerlead sponsor
National Cancer Institute (NCI)collaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT03291938 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.